REQUEST A DEMO
Total
USD $0.00
Search more companies

Nanolek OOO (Нанолек ООО) (Russia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Nanolek OOO Profile Updated: October 16, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Russian Download a sample report

Nanolek OOO (Нанолек ООО) is based in Russia, with the head office in Moscow. The enterprise currently operates in the Pharmaceutical Preparation Manufacturing sector. It was first established on April 28, 2011. It currently has a total number of 501 - 1,000 (2024) employees. There was a net sales revenue increase of 39.63% reported in Nanolek OOO (Нанолек ООО)’s latest financial highlights for 2024. A growth of 0.13% was recorded in its total assets. In 2024, Nanolek OOO (Нанолек ООО)’s net profit margin decreased by 3.94%.

Headquarters
Butyrskii Val, 68/70, 1, 2 Pom I Kom 23-37
Moscow; Moscow; Postal Code: 127055

Contact Details: Purchase the Nanolek OOO (Нанолек ООО) report to view the information.

Basic Information
Total Employees:
Purchase the Nanolek OOO (Нанолек ООО) report to view the information.
Registered Capital:
Purchase the Nanolek OOO (Нанолек ООО) report to view the information.
Financial Auditors:
Purchase the Nanolek OOO (Нанолек ООО) report to view the information.
Incorporation Date:
April 28, 2011
Key Executives
Purchase this report to view the information.
General Director
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Immolab OOO
99%
Invak OOO
60%
Company Performance
Financial values in the chart are available after Nanolek OOO (Нанолек ООО) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency RUB. Absolute financial data is included in the purchased report.
Net sales revenue
39.63%
Total operating revenue
39.63%
Operating profit (EBIT)
11.81%
Net Profit (Loss) for the Period
-50.4%
Total assets
0.13%
Total equity
-6.69%
Operating Profit Margin (ROS)
-2.82%
Net Profit Margin
-3.94%
Return on Equity (ROE)
-12.26%
Debt to Equity Ratio
48.1%
Quick Ratio
0.14%
Cash Ratio
0.19%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?